Microscopic colitis
Authors:
Karel Lukáš 1; Václav Mandys 2
Authors place of work:
IV. interní klinika 1. LF UK a VFN, Praha
1; Ústav patologie 3. LF UK, Praha
2
Published in the journal:
Čas. Lék. čes. 2013; 152: 59-66
Category:
Review Article
Summary
Microscopic colitis is characterized by chronic or intermittent watery diarrhoea. Microscopic colitis is a common cause of chronic diarrhoea in predominantly older adults. The underlying mechanism in the pathogenesis of microscopic colitis remains unspecified. Microscopic colitis including colitis collagenous, lymphocytic, microscopic colitis with incomplete findings, minimal change colitis, eosinophilic colitis, Brainerd´s diarrhoea, graft-versus-host disease, mastocytic enterocolitis and postinfectious irritable bowel syndrome. Careful consideration of the clinical features and colonic mucosal biopsies usually lead to correct diagnosis. Treatments of microscopic colitis were based primarily on case reports and personal experience. Many medications have been proposed that either offer symptomatic relief (loperamide, cholestyramine) or had anti-inflammatory or immunosuppressive properties (aminosalicylates, steroids, adalimumab, azathioprine). Keywords: microscopic colitis – collagenous colitis – lymphocytic colitis – eosinophilic colitis – postinfectious irritable bowel syndrome – aminosalicylates – steroids – adalimumab – azathioprin
Zdroje
1. Willliams JJ, Beck PL, Andrews CN, Hogan DB, Storr MA. Microscopic colitis-a common cause of diarrhoea in older adults. Age and Ageing 2010; 39: 162–168.
2. Münch A, Aust D, Bohr J, et al. Microscopic colitis: Current status, present and future challenges: Statements of the EMCG. J Crohns Colitis 2012; 6: 935–945.
3. Langner C. Colorectal normal histology and histopathologic findings in patients with chronic diarrhea. Gastroenterol Clin North Am 2012; 41: 561–580.
4. Vigren L, Olesen M, Benoni C, Sjöberg K. Are collagenous and lymphocytic colitis different aspects of the same disease? Scand J Gastroenterol 2012; 47: 1448–1453.
5. Lindström CG. „Collagenous colitis“ with watery diarrhoea-new entity. Pathol Eur 1976; 11: 87.
6. Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM. Lymphocytic („microscopic“) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 1989; 20: 18–20.
7. Read NW, Krejs GJ, Read MG. Chronic diarrhea of unknown origin. Gastroenterology 1980; 78: 264–269.
8. Guagnozzi D, Lucendo AJ, Angueira-Lapeña T, González-Castillo S, Tenias Burillo JM. Prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain. Dig Liver Dis 2012; 44: 384–388.
9. Zullo A, Hassan C, Bruzzese V. Comment to „prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain“. Dig Liver Dis 2012; 44: 801–802.
10. Pardi DS, Loftus EV Jr, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007; 56: 504–508.
11. Marshall JB, Singh R, Diaz-Arias AA. Chronic, unexplained diarrhea: are biopsies necessary if colonoscopy is normal? Am J Gastroenterol 1995; 90: 372–376.
12. Fernández-Bañares F, Salas A, Esteve M, et al. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study. Inflamm Bowel Dis 2011; 17: 1015–1020.
13. Chetty R, Govender D. Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis. Nat Rev Gastroenterol Hepatol 2012; 9: 209–218.
14. Rustagi T, Rai M, Scholes JV. Collagenous gastroduodenitis. J Clin Gastroenterol 2011; 45: 794–799.
15. Breen EG, Coughlan G, Connoly CE, et al. Coeliac proctitis. Scand J Gastroenterol 1987; 22: 471–477.
16. Fine KD, Meyer LR, Lee EL. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology 1997; 112: 1830–1838.
17. Koulaouzidis A, Saeed AA. Distinct colonoscopy findings of microscopic colitis: not so microscopic after all? World J Gastroenterol 2011; 17: 4157–4165.
18. Sherid M, Ehrenpreis ED. Types of colitis based on histology. Dis Mon 2011; 57: 457-89.
19. Villanacci V, Casella G, Bassotti G. The spectrum of drug-related colitides: important entities, though frequently overlooked. Dig Liver Dis 2011; 43: 523–528.
20. Capurso G, Marignani M, Attilia F, et al. Lansoprazole-induced microscopic colitis: an increasing problem? Results of a prospecive case-series and systematic review of the literature. Dig Liver Dis 2011; 43: 380–385.
21. Keszthelyi D, Penders J, Masclee AA, Pierik M. Is Microscopic Colitis a Drug-induced Disease? J Clin Gastroenterol 2012; 46: 811–822.
22. Yu YH, Han DS, Choi EY, et al. Is use of PPIs related to increased intraepithelial lymphocytes in the colon? Dig Dis Sci 2012; 57: 2669–2674.
23. Yen EF, Pokhrel B, Du H, et al. Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis 2012; 18: 1835–1841.
24. Juckett G, Trivedi R. Evaluation of chronic diarrhea. Am Fam Physician 2011; 84: 1119–1126.
25. Wenzl HH. Diarrhea in chronic inflammatory bowel diseases. Gastroenterol Clin North Am 2012; 41: 651–675.
26. Pardi DS. Microscopic colitis: an update. Inflamm Bowel Dis 2004; 10: 860–870.
27. Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease - microscopic colitis? Aliment Pharmacol Ther 2012; 36: 79–90.
28. Gado AS, Ebeid BA, El Hindawi AA, Akl MM, Axon AT. Prevalence of microscopic colitis in patients with chronic diarrhea in Egypt: a single-center study. Saudi J Gastroenterol 2011; 17: 383–386.
29. Bharucha AE, Zinsmeister AR, Locke GR, et al. Risk factor for fecal incontinence: a population-based study in women. Am J Gastroenterol 2006; 101: 1305–1312.
30. Gu HX, Zhi FC, Huang Y, Li AM, Bai Y, Jiang B, Zhang YL. Microscopic colitis in patients with chronic diarrhea and normal colonoscopic findings in Southern China. Int J Colorectal Dis 2012; 27: 1167–1173.
31. Fraser AG, Warren BF, Chandrapala R, Jewell DP. Microscopic colitis: a clinical and pathological review. Scand J Gastroenterol 2002: 37: 1241–1245.
32. Bonderup OK, Folkersen BH, Gjersoe P, Teglbjaerg PS. Collagenous colitis: a long-term follow-up study. Eur J Gastroenterol Hepatol 1999; 11: 493–495.
33. Freeman HJ. Long-term natural history and complications of collagenous colitis. Can J Gastroenterol 2012; 26: 627–630.
34. Milestone AN, Teare JP, Goldin RD. W1498: Linear Ulceration in Collagenous Colitis. A Case Series and Literature Review. Gastrointestinal Endoscopy 2011; 71: AB343.
35. Sherman A, Ackert JJ, Rajapaksa R, West AB, Oweity T. Fractured colon: an endoscopically distinctive lesion associated with colonic perforation following colonoscopy in patients with collagenous colitis. J Clin Gastroenterol 2004; 38: 341–345.
36. Hussain Z, Kelly S, Clarke A, Adams S, Miller G. Colonic perforation in collagenous colitis: a systematic review of a rare complication and guidance on management. Surg Endosc 2010; 24: 2930–2934.
37. Sekioka T, Saitou M, Tanaka T, et al. A Case of Lansoprazole-associated Collagenous Colitis with Peritonitis Accompanying Endoscopically Fractured Colon. Nippon Daicho Komonbyo Gakkai Zasshi 2009; 62: 527–533.
38. van Velden R, Snieders I, Quispel R. Image of the month. Tearing of the colon in a patient with collagenous colitis during colonoscopy. Clin Gastroenterol Hepatol. 2010; 8: A28.
39. Pardi DS. Miscellaneous colitides. Curr Opin Gastroenterol 2012; 28: 76–81.
40. Tanaka M, Mazzoleni G, Riddel RH. Distribution of collagenous colitis: utility of flexible sigmoidoscopy. Gut 1992; 33: 65–70.
41. Thijs WJ, Kleibeuker JH, Kolkman JJ. Microscopic colitis: prevalence and distribution throughout the colon in pateints with chronic diarrhea. Neth J Med 2005; 63: 137–140.
42. Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endoscop 2000; 51: 318–326.
43. Günter U, Bateman AC, Beattie RM, Bauer M, MacDonald TT. Kaskas BA. Connective tissue growth factor expression is increased in collagenous colitis and coelica disease. Histopathology 2010; 57: 427–435.
44. Madalinski M, Koulaouzidis A. Collagenous colitis with mucosal tears in two proton-pump inhibitors and non-steroidals naïve patients who developed metachronous cancers. J Dig Dis 2012 Sep 21. doi: 10.1111/j. 17512980.2012.00646.x.
45. Narabayashi K, Murano M, Egashira Y, et al. Endoscopic and histopathological evaluation of collagenous colitis. Digestion 2012; 85: 136–140.
46. Majores M, Wunsch S, Blume B, Fischer HP, Reichel C. Mucosal atrophy in collagenous colitis: a case report. BMC Gastroenterol 2011; 11: 114–119.
47. Platz-Baudin C, Katzenberger T, Eck M. Microscopic colitis: histopathological review with a clinicopathological correlation. Pathologe 2011; 32: 275–281.
48. Aust DE. Histopathology of microscopic colitis. Pathologe 2012; 33: 221–224.
49. Müller S, Neureiter D, Stolte M, et al. Tenascin: a sensitive and specific diagnostic marker of minimal collagenous colitis. Virchows Arch 2001; 438: 435–441.
50. Salas A, Fernández-Bañares F, Casalots J, et al. Subepithelial myofibroblasts and tenascin expression in microscopic colitis. Histopathology 2003; 43: 48–54.
51. Denız K, Coban G, Ozbakir O, Denız E. Pseudomembranous collagenous colitis. Turk J Gastroenterol 2012; 23: 93–95.
52. Buchman AL, Rao S. Pseudomembranous collagenous colitis. Dig Dis Sci 2004; 49: 1763–1767.
53. El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. World J Gastroenterol 2012; 18: 6070–6075.
54. Olesen M, Eriksson S, Bohr J, et al. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients, Gut 2004; 54: 536–541.
55. Mohamed N, Marais M, Bezuidenhout J. Microscopic colitis as a missed cause of chronic diarrhea. World J Gastroenterol. 2011; 17: 1996–2002.
56. Bjørnbak C, Engel PJ, Nielsen PL, Munck LK. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther 2011; 34: 1225–1234.
57. O‘Brien BH, McClymont K, Brown I. Collagenous ileitis: a study of 13 cases. Am J Surg Pathol 2011; 35: 1151–1157.
58. Elliot PR, Lennard-Jones JE, Bartram CI, et al. Colonoscopic diagnosis of minimal change colitis in patients with a normal sigmoidoscopy and normal air-contrast barium enema. Lancet 1982; 8273: 650–651.
59. Kingham JGC, Levison DA, Ball JA, Dawson AM. Microscopic colitis-a cause of chronic watery diarrhoea. Brit Med J 1982; 285: 1601–1604.
60. Warren BF, Edwards CM, Travis SPL. Microscopic colitis‘: classification and terminology. Histopathology 2002; 40: 374–376.
61. Alfadda AA, Storr MA, Shaffer EA. Eosinophilic colitis: an update on pathophysiology and treatment. Br Med Bull 2011; 100: 59–72.
62. Okpara N, Aswad B, Baffy G. Eosinophilic colitis. World J Gastroenterol 2009; 15: 2975–2979.
63. Talley NJ, Shorter RG, Phillips SF, et al. Eosinophilic gastroenteritis. A clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990; 31: 54–58.
64. Lee CM, Changchien CS, Chen PC, et al. Eosinophilic gastroenteritis. 10 years experience. Am J Gastroenterol 1993; 88: 70–74.
65. Croese J, Loukas A, Opdebeeck J, et al. Human enteric infection with canine hookworms. Ann Intern Med 1994; 120: 369–374.
66. Talley NJ. Eosinophilic gastroenteritis. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisenger & Fordtran’s gastrointestinal and liver disease, Vol. 2, 6th ed. Philadelphia: WB Saunders 1998; 1679–1688.
67. Carpenter HA, Talley NJ. The importance of Clinicopathological Correlation in the Diagnosis of Inflammatory Conditions of the Colon: Histological Patterns with Clinical Implications. Amer J Gastroenterology 2000; 95: 878–896.
68. Gaertner WB, Macdonald JE, Kwaan MR, et al. Eosinophilic colitis: university of Minnesota experience and literature review. Gastroenterol Res Pract 2011; 2011: 857–858.
69. Clouse RE, Alpers DH, Hockenbery DM, et al. Pericrypt eosinophilic enterocolitis and chronic diarrhea. Gastroenterology 1992; 103: 168–176.
70. Villanacci V, Manenti S, Antonelli E, Chiudinelli M, Giuliano V, Bassotti G. Non-IBD colitides: clinically useful histopathological clues. Rev Esp Enfermed Dig 2011; 103: 366–372.
71. Casella G, Villanacci V, Fisogni S, Cambareri AR, Di Bella C, Corrazi N, et al. Colonic left-side increase of eosinophils: a clue to drug-related colitis in adults. Aliment Pharmacol Ther 2009; 29: 535–541.
72. Osterholm MT, MacDonald KL, White KE, et al. An Outbreak of newly recognized chronic diarrhea associated with raw milk. JAMA 1986; 256: 484–490.
73. Parsonnet J, Trock SC, Bopp CA, et al. Chronic diarrhea associated with drinking untreated. Ann Intern Med 1989; 110: 985–991.
74. Mintz ED, Weber JT, Guris D, et al. An outbreak of Brainerd diarrhea among travelers to the Galapagos Islands”. J Infect Dis 1989; 177: 1041–1045.
75. Kimura AC, Mead P, Walsh B, et al. A large outbreak of Brainerd diarrhea associated with a restaurant in the Red River Valley, Texas. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2006; 43: 55–61.
76. Mintz ED, Parsonnet J, Osterholm MT. Chronic idiopathic diarrhea. New Engl J Med 1993; 328: 1713–1714.
77. Afzalpurkar RG, Schiller LR, Little KH, et al. The self limiting nature of chronic idiopathic diarrhea. New Engl J Med 1992; 327: 1849–1852.
78. Snover DC, Weisdorf SA, Vercelloti GM, et al. A histopathologic study of gastric and small intestinal graft-versus-host disease following allogenic bone marrow transplantation. Hum Pathol 1985; 16: 387–392.
79. Kornacki S, Hansen FC III, lazenby A. Graft-versus-host like colitis associated with malignant thymoma. Am J Surg Pathol 1995; 19: 224–228.
80. Nováková L, Kučera P. Systémová mastocytóza. Transfuze Hematol 2009; 15: 31–38.
81. Doubek M, Kozák T, Vašků V, Szturz P, Tichá M, Křen L. Systémová mastocytóza. Vnitř. Lék. 2010; 56(Suppl 2): 188–194.
82. Philpott H, Gow P, Crowley P, Nandurkar S, Douglass J, Gibson PR. Systemic mastocytosis: a gastroenterological perspective. Frontline Gastroenterol 2012; 3: 5–9.
83. Söderholm JD, Olaison G, Peterson KH, Franzén LE, Lindmark T, Wirén M, Tagesson C, Sjödahl R. Mast Cell and mastocytosis. Dig Dis 2009; 27(Suppl1): 129–136.
84. Yen EF, Pardi DS. Microscopic colitis and disease associations. Alimentary Pharmacology & Therapeutics 2011; 34: 820–821.
85. Yen EF, Pardi DS. Review article: Microscopic colitis-lymphocytic, collagenous and ‚mast cell‘ colitis. Aliment Pharmacol Ther 2011; 34: 21–32.
86. Liszka Ł, Woszczyk D, Pajak J. Histopathological diagnosis of microscopic colitis. J Gastroenterol Hepatol 2006; 21: 792–797.
87. Kirsch R, Riddell RH. Histopathological alterations in irritable bowel syndrome. Mod Pathol 2006; 19: 1638–1645.
88. Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007; 42(Suppl 17): 41–47.
89. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003; 124: 1662–1671.
90. Barbara G, Cremon C, Pallotti F, DeGiorgio R, Stanghellini V, Corinaldesi R. Postinfectious irritable bowel syndrome. J Pediatr. Gastroenterol Nutr 2009; 48(Suppl 2): S95–97.
91. Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol 2011; 46: 421–431.
92. De Giorgio R, Barbara G. Is irritable bowel syndrome an inflammatory disorder? Curr Gastroenterol Rep 2008; 10: 385–390.
93. Ozdil K, Sahin A, Calhan T, et al. The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome. BMC Gastroenterol 2011; 11: 96.
94. Goff JS, Barnett JL, Pelke T, Appelman HD. Collagenous colitis: histopatology and clinical course. Am J Gastroenterol 1997; 92: 57–60.
95. Bohr J, Tysk C, Eriksson S, Abrahamsson H, Jarnerot G. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996; 39: 846–851.
96. Zins BJ, Tremaine WJ, Carpenter HA. Collagenous colitis: mucosal biopsies and association with fecal leucocytes. Mayo Clin Proc 1995; 70: 430–433.
97. Chande N. Microscopic colitis: An approach to treatment. Can J Gastroenterol 2008; 2: 686–688.
98. Fine KD, Lee EL. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology 1998; 114: 29–36.
99. Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999; 116: 1464–1486.
100. Pardi DS, Ramnath VR, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol 2002; 97: 2829–2833.
101. Hatemi AI, Senateş E, Dobrucali A, Göksel S. Collagenous colitis: a retrospective survey of patients with chronic diarrhea. Hepato-gastroenterology 2011; 58: 1963–1967.
102. Calabrese C, Fabbri A, Areni A, Zahlane D, Scialpi C, Di FG. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J Gastroenterol Hepatol 2007; 22: 809–814.
103. Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009; 104: 235–241.
104. El-Matary W, Girgis S, Huynh H, Turner J, Diederichs B. Microscopic colitis in children. Dig Dis Sci 2010; 55: 1996–2001.
105. Munck LK, Kjeldsen J, Philipsen E, Fischer HB. Incomplete remission with short-term prednislone treatment in collagenous colitis: a randomized study. Scand J Gastroenterol 2003; 38: 606–610.
106. Pardi DS, Loftus EV Jr, Treamaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology 2001; 120: 1483–1484.
107. Riddell J, Hillman L, Chiragakis L, Clarke A. Collagenous colitis: oral low-dose methotrexate for patients with difficult symptoms: long-term outcomes. J Gastroenterol Hepatol 2007; 22: 1589–1593.
108. Tangri V, Chande N. Use of budesonide in the treatment of microscopic colitis Saudi J Gastroenterol 2010; 16: 236–238.
109. Madisch A, Heymer P, Voss C, et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis 2005; 20: 312–316.
110. Miehlke S, Madisch A, Voss C, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 2005; 22: 1115–1119.
111. Mahajan D, Goldblum JR, Xiao SY, Shen B, Liu X. Lymphocytic colitis and collagenous colitis: a review of clinicopathologic features and immunologic abnormalities. Adv Anat Pathol 2012; 19: 28–38.
112. Münch A, Ignatova S, Ström M. Adalimumab in budesonide and methotrexate refractory collagenous colitis.Scand J Gastroenterol 2012; 47: 59–63.
113. Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A, Fernández-Bañares F. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis 2011; 5: 612–618.
114. Aram G, Bayless TM, Chen ZM, Montgomery EA, Donowitz M, Giardiello FM. Refractory lymphocytic enterocolitis and tumor necrosis factor antagonist therapy. Clin Gastroenterol Hepatol 2010; 8: 391–394.
115. Ianiro G, Cammarota G, Valerio L, Annicchiarico BE, Milani A, Siciliano M, Gasbarrini A. Microscopic colitis. World J Gastroenterol 2012; 18: 6206–6215.
116. Madisch A, Miehlke S, Eichele O, et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. Int J Colorectal Dis 2007; 22: 1445–1451.
117. Wildt S, Munck LK, Vinter-Jensen L, et al. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. Inflamm Bowel Dis 2006; 12: 395–401.
118. Tromm A, Niewerth U, Khoury M, et al. The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial. Z Gastroenterol 2004; 42: 365–369.
119. McNally MA, Smyrk TC, Tremaine WJ. Miscellaneous inflammatory and structural disorders of the colon. In: Textbook of Gastroenterology. Yamada T. ed. Chichester: Willey-Blackwell 2009: 1507–1535.
120. Fernández-Bañares F, Salas A, Forné M, Esteve M, Espinós J, Viver JM. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 1999; 94: 418–423.
121. Yen EF, Pardi DS. Review of the Microscopic Colitides. Current Gastroenterology Reports 2011; 13: 458–464.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Microscopic colitis
- Irreversible electroporation: local, non-thermal, ablation therapy of malignant tumours
- Long-term problem with addictive substances dependence and its solution: a case report
- Marcus Tullius Cicero and medicine